Why the study?
Do cardiac enzyme levels and lipid profiles differ between patients with acute myocardial infarction and normal subjects?
Case-Control (n=45)
No
Do cardiac enzyme levels and lipid profiles differ between patients with acute myocardial infarction and normal subjects?
Patients with acute myocardial infarction demonstrate significantly elevated cardiac enzymes and an atherogenic lipid profile compared to healthy controls.
Supports established enzyme kinetics and lipid associations in AMI; extends case-control data but leaves open broader applicability.
The term Myocardial infarction signifies sudden necrosis or death of a portion of cardiac muscle due to inadequate blood supply [1]. Myocardial infarction results from prolonged myocardial coronary thrombus at the site of a pre-existing atherosclerotic stenosis [2]. The major cause of acute myocardial infarction is atherosclerosis [3]. It is three to four times more frequent among men than women [4].
No takes yet. Share an insight, caveat, or question.
Sudha Rani Yeluri (2018) conducted a case-control in Acute Myocardial Infarction (n=45). Acute Myocardial Infarction vs. Healthy controls was evaluated on Serial serum enzyme levels (CK, CK-MB, LDH, AST) and lipid profile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: